Filter
141
Filtered Results: 141
Text search:
UNITAID,
WHO,
Global
Laboratory
Initiative,
et.
al
Featured
Recommendations
16
New Publications
29
Language
Document type
No document type
71
Studies & Reports
28
Guidelines
24
Strategic & Response Plan
8
Manuals
6
Training Material
1
Brochures
1
Infographics
1
Fact sheets
1
Countries / Regions
Global
7
Africa
4
India
4
Eastern Europe
3
Ethiopia
3
Kenya
2
Cameroon
2
Burkina Faso
2
Mozambique
2
Western and Central Europe
2
Uganda
2
Myanmar / Burma
2
Timor Leste/ East Timor
1
Nigeria
1
Malawi
1
Asia
1
West and Central Africa
1
Middle East and North Africa
1
East and Southern Africa
1
Bangladesh
1
Brazil
1
Moldova
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
28
Clinical Guidelines
28
Pharmacy & Technologies
6
Women & Child Health
5
Public Health
4
Key Resources
2
Toolboxes
HIV
49
TB
28
Health Financing Toolbox
7
COVID-19
5
AMR
4
Rapid Response
2
Mental Health
2
Pharmacy
2
Refugee
1
Ebola & Marburg
1
Caregiver
1
NCDs
1
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
2nd edition
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
A progress report
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
Supplément
Décembre 2016
Services de dépistage du VIH
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Supplement
HIV testing services
December 2016
